Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report

BACKGROUND: Perivascular epithelioid cell tumors are defined by the World Health Organization as “a collection of rare mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells.” Whereas localized perivascular epithelioid cell tumor is typical...

Descripción completa

Detalles Bibliográficos
Autores principales: McBride, Ali, Garcia, Andrew J., Sanders, Lauren J., Yiu, Kelly, Cranmer, Lee D., Kuo, Phillip H., Kay, Matthew, Kraft, Andrew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305520/
https://www.ncbi.nlm.nih.gov/pubmed/34301321
http://dx.doi.org/10.1186/s13256-021-02997-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305520/
https://www.ncbi.nlm.nih.gov/pubmed/34301321
http://dx.doi.org/10.1186/s13256-021-02997-x

Ejemplares similares